Progetto FRRB ID 4987503 - OMics-based newborn integrated screening for accurate false-positive easing: discovery of new signatures with an artificial intelligence approach (OMNISAFE)
Dati del progetto
Principal Investigator |
Dr.ssa Clarissa Berardo |
Ente ospitante |
ASST Fatebenefratelli Sacco |
Area Tematica |
Malattie Rare |
Data di inizio Progetto |
07/01/2025 |
Data di fine Progetto |
06/01/2028 |
Importo assegnato |
499.999,80 € |
Tipo Progetto |
Individuale |
PROJECT AIMS
Newborn screening (NBS) is a preventive medicine program that allows the identification of metabolic diseases in still asymptomatic infants, reducing both the risk of serious developmental damage to the child and the social impact on families and National Health System. The main aims of this project are:
- Reducing the number of false positives;
- Increasing genetic rate diagnosis;
- Identifiying new and more selective molecular markers to be included in innovated NBS.